Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect. | Front Immunol | 2022 | 36159856 | PubTator, text mining | PubMed |
| CARD9 deficiency predisposing chromoblastomycosis: A case report and comparative transcriptome study. | Front Immunol | 2022 | 36159827 | PubTator, text mining | PubMed |
| A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease. | Front Immunol | 2022 | 36148224 | PubTator, text mining | PubMed |
| Integrating knowledge of protein sequence with protein function for the prediction and validation of new MALT1 substrates. | Comput Struct Biotechnol J | 2022 | 36147669 | PubTator, text mining | PubMed |
| Circulating MicroRNAs Expression Profile in Lung Inflammation: A Preliminary Study. | J Clin Med | 2022 | 36143090 | PubTator, text mining | PubMed |
| Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer. | Genes (Basel) | 2022 | 36140808 | PubTator, text mining | PubMed |
| Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities. | Cells | 2022 | 36139483 | PubTator, text mining | PubMed |
| A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease. | Cells | 2022 | 36139421 | PubTator, text mining | PubMed |
| Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer. | Cell Death Dis | 2022 | 36138018 | PubTator, text mining | PubMed |
| Alternative Routes of Administration for Therapeutic Antibodies-State of the Art. | Antibodies (Basel) | 2022 | 36134952 | PubTator, text mining | PubMed |
| Th17-Derived Cytokines Synergistically Enhance IL-17C Production by the Colonic Epithelium. | J Immunol | 2022 | 36130829 | PubTator, text mining | PubMed |
| High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients. | Front Oncol | 2022 | 36119497 | PubTator, text mining | PubMed |
| Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36119473 | PubTator, text mining | PubMed |
| Advances in vitiligo: Update on therapeutic targets. | Front Immunol | 2022 | 36119071 | PubTator, text mining | PubMed |
| Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure. | Mediators Inflamm | 2022 | 36117587 | PubTator, text mining | PubMed |
| Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA. | An Bras Dermatol | 2022 | 36117047 | PubTator, text mining | PubMed |
| The CD4+ T cell response to a commensal-derived epitope transitions from a tolerant to an inflammatory state in Crohn's disease. | Immunity | 2022 | 36115338 | PubTator, text mining | PubMed |
| Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab. | Dermatol Ther | 2022 | 36111349 | PubTator, text mining | PubMed |
| Exosome Derived from Mesenchymal Stem Cells Alleviates Pathological Scars by Inhibiting the Proliferation, Migration and Protein Expression of Fibroblasts via Delivering miR-138-5p to Target SIRT1. | Int J Nanomedicine | 2022 | 36105616 | PubTator, text mining | PubMed |
| Cardiac biomarkers and detection methods for myocardial infarction. | Mol Cell Toxicol | 2022 | 36105117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=46